Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward.
STD/STI
diagnostics
key and vulnerable populations
point of care
treatment
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
30
01
2019
accepted:
18
06
2019
entrez:
31
8
2019
pubmed:
31
8
2019
medline:
16
7
2020
Statut:
ppublish
Résumé
Sexually transmitted infections (STIs) remain prevalent and are increasing in several populations. Appropriate STI diagnosis is crucial to prevent the transmission and sequelae of untreated infection. We reviewed the diagnostic accuracy of syndromic case management and existing point-of-care tests (POCTs), including those in the pipeline, to diagnose STIs in resource-constrained settings. We prioritized updating the systematic review and meta-analysis of the diagnostic accuracy of vaginal discharge from 2001 to 2015 to include studies until 2018. We calculated the absolute effects of different vaginal flowcharts and the diagnostic performance of POCTs on important outcomes. We searched the peer-reviewed literature for previously conducted systematic reviews and articles from 1990 to 2018 on the diagnostic accuracy of syndromic management of vaginal and urethral discharge, genital ulcer and anorectal infections. We conducted literature reviews from 2000 to 2018 on the existing POCTs and those in the pipeline. The diagnostic accuracy of urethral discharge and genital ulcer disease syndromes is relatively adequate. Asymptomatic Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections limit the use of vaginal discharge and anorectal syndromes. The pooled diagnostic accuracy of vaginal syndromic case management for CT/NG is low, resulting in high numbers of overtreatment and missed treatment. The absolute effect of POCTs was reduced overtreatment and missed treatment. Findings of the reviews on syndromic case management underscored the need for low-cost and accurate POCTs for the identification, first, of CT/NG, and, second, of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) and NG and MG resistance/susceptibility testing. Near-patient POCT molecular assays for CT/NG/TV are commercially available. The prices of these POCTs remain the barrier for uptake in resource-constrained settings. This is driving the development of lower cost solutions. The WHO syndromic case management guidelines should be updated to raise the quality of STI management through the integration of laboratory tests. STI screening strategies are needed to address asymptomatic STIs. POCTs that are accurate, rapid, simple and affordable are urgently needed in resource-constrained settings to support the uptake of aetiological diagnosis and treatment.
Identifiants
pubmed: 31468679
doi: 10.1002/jia2.25343
pmc: PMC6715950
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25343Subventions
Organisme : NIAID NIH HHS
ID : R13 AI138840
Pays : United States
Organisme : World Health Organization's Human Reproduction Programme
Pays : International
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 World Health Organization; licensed by IAS.
Références
Sex Transm Infect. 2003 Oct;79(5):363-7
pubmed: 14573829
Sex Transm Infect. 2016 Feb;92(1):24-8
pubmed: 26136508
Stud Fam Plann. 2000 Mar;31(1):55-68
pubmed: 10765538
PLoS One. 2012;7(12):e51685
pubmed: 23272140
BMC Infect Dis. 2017 Feb 18;17(1):155
pubmed: 28214469
Sex Transm Dis. 2015 Aug;42(8):450-6
pubmed: 26165437
Int J STD AIDS. 2003 Feb;14(2):109-13
pubmed: 12662389
Sex Transm Dis. 2011 Jun;38(6):503-9
pubmed: 22256336
Lancet Infect Dis. 2017 Aug;17(8):e235-e279
pubmed: 28701272
Sex Transm Infect. 2010 Nov;86(6):440-1
pubmed: 20656722
Sci Rep. 2018 Jul 31;8(1):11503
pubmed: 30065272
PLoS One. 2018 Dec 3;13(12):e0208107
pubmed: 30507962
BMC Infect Dis. 2018 Dec 18;18(1):675
pubmed: 30563478
Am J Obstet Gynecol. 2017 Jan;216(1):1-9
pubmed: 28007229
Expert Rev Mol Diagn. 2017 Sep;17(9):845-859
pubmed: 28741392
Sex Transm Infect. 2008 Oct;84(5):400-4
pubmed: 18426845
Infect Dis Obstet Gynecol. 2016;2016:5758387
pubmed: 27366021
Sex Transm Infect. 1998 Jun;74 Suppl 1:S128-32
pubmed: 10023363
PLoS One. 2017 Jul 27;12(7):e0182005
pubmed: 28750083
Trop Med Int Health. 2018 May;23(5):541-548
pubmed: 29505113
J Adolesc Health. 2009 Nov;45(5):463-72
pubmed: 19837352
Sex Transm Dis. 2018 Apr;45(4):272-277
pubmed: 29528987
Lancet. 1995 Aug 26;346(8974):530-6
pubmed: 7658778
Biomed Microdevices. 2018 Apr 11;20(2):35
pubmed: 29644437
Sex Transm Infect. 2018 Aug;94(5):340-345
pubmed: 29748180
Sex Transm Infect. 2006 Dec;82 Suppl 5:v29-32
pubmed: 17215275
PLoS One. 2016 Oct 5;11(10):e0163365
pubmed: 27706174
Bull World Health Organ. 2001;79(2):118-26
pubmed: 11242818
PLoS One. 2013;8(2):e54695
pubmed: 23468842
J Infect Dis. 2012 Jul 1;206(1):6-14
pubmed: 22517910
PLoS Med. 2017 Jul 7;14(7):e1002344
pubmed: 28686231
Lancet Infect Dis. 2019 Jun;19(6):658-669
pubmed: 31031172
Sex Transm Infect. 2014 Feb;90(1):46-51
pubmed: 23920398
AIDS Patient Care STDS. 2009 Jun;23(6):443-8
pubmed: 19519228
Sex Transm Infect. 2013 Mar;89(2):108-14
pubmed: 22984085
PLoS One. 2015 Dec 29;10(12):e0145993
pubmed: 26713441
Int J STD AIDS. 2018 Apr;29(5):474-482
pubmed: 29059032
Sex Transm Infect. 2017 Dec;93(S4):S22-S30
pubmed: 29223960
PLoS One. 2014 Jun 23;9(6):e100518
pubmed: 24956111
PLoS Med. 2017 Dec 27;14(12):e1002479
pubmed: 29281628
Sex Transm Infect. 2017 Dec;93(S4):S16-S21
pubmed: 29223959
Nat Rev Urol. 2017 Mar;14(3):139-152
pubmed: 28072403
J Clin Microbiol. 2013 Sep;51(9):2913-20
pubmed: 23804384
J Infect Dis. 2012 Jul 1;206(1):1-2
pubmed: 22517911
Sex Transm Infect. 2006 Dec;82 Suppl 5:v1-6
pubmed: 17151023
Diagnostics (Basel). 2017 Nov 29;7(4):
pubmed: 29186013
Clin Biochem Rev. 2013 Aug;34(2):61-74
pubmed: 24151342
Sex Transm Infect. 2007 Jun;83(3):242-5
pubmed: 17314124
Sex Transm Dis. 2005 Jul;32(7):425-36
pubmed: 15976600
Infect Dis Obstet Gynecol. 2018 May 9;2018:3946862
pubmed: 29861622
J Clin Microbiol. 2013 Jun;51(6):1945-7
pubmed: 23554203
Point Care. 2012 Jun;11(2):130-139
pubmed: 22919287
Clin Infect Dis. 2016 Sep 1;63(5):627-633
pubmed: 27217216
PLoS One. 2017 May 31;12(5):e0178653
pubmed: 28562672
Sex Transm Infect. 2017 Nov;93(7):458-459
pubmed: 28778981
PLoS One. 2018 Apr 24;13(4):e0196209
pubmed: 29689080
Sex Transm Dis. 2000 Aug;27(7):371-85
pubmed: 10949428
J Int AIDS Soc. 2019 Aug;22 Suppl 6:e25343
pubmed: 31468679
Sex Transm Dis. 2018 Sep;45(9):615-622
pubmed: 29485537
Sex Transm Dis. 2012 Nov;39(11):906-10
pubmed: 23064541
J Clin Microbiol. 2015 Apr;53(4):1348-50
pubmed: 25609726
Sex Transm Infect. 2004 Jun;80(3):174-82
pubmed: 15169997
Sex Transm Infect. 2009 Sep;85(5):354-8
pubmed: 19351623
Sex Transm Dis. 2003 Apr;30(4):327-30
pubmed: 12671553
Sex Transm Dis. 2018 Apr;45(4):278-279
pubmed: 29528988
Clin Microbiol Infect. 2019 Mar;25(3):380.e1-380.e7
pubmed: 29906594
Sex Transm Infect. 2017 Dec;93(S4):S31-S35
pubmed: 28684611
Sex Transm Infect. 2013 Sep;89(6):434-8
pubmed: 23633669
J Med Microbiol. 2014 Aug;63(Pt 8):1111-1112
pubmed: 24907352
Expert Rev Anti Infect Ther. 2014 Jun;12(6):657-72
pubmed: 24484215
BMJ Open. 2017 Dec 29;7(12):e018630
pubmed: 29288183
Sex Transm Infect. 2014 Mar;90(2):104-11
pubmed: 24273127
PLoS One. 2013 May 21;8(5):e63953
pubmed: 23704961
Am J Epidemiol. 2019 Mar 1;188(3):545-554
pubmed: 30608525
Sex Transm Infect. 2006 Oct;82(5):403-12
pubmed: 17012515
Sex Transm Dis. 1999 Apr;26(4):232-40
pubmed: 10225593
Infect Dis Obstet Gynecol. 2016;2016:4386127
pubmed: 27313440
Sex Transm Infect. 2017 Dec;93(S4):S65-S68
pubmed: 28684610
PLoS Med. 2012;9(9):e1001306
pubmed: 22973183
An Bras Dermatol. 2017 Nov-Dec;92(6):779-784
pubmed: 29364432
BMC Infect Dis. 2016 Jun 06;16:250
pubmed: 27268218
Sex Transm Infect. 2012 Jun;88(4):288-93
pubmed: 22328644
J Clin Microbiol. 2013 Jun;51(6):1666-72
pubmed: 23467600
Sex Transm Dis. 2012 Oct;39(10):787-91
pubmed: 23001266
BMJ Open. 2017 Jun 14;7(6):e015447
pubmed: 28615273
Lancet. 1998;351 Suppl 3:5-7
pubmed: 9652712
Sex Transm Dis. 2018 Nov;45(11):723-727
pubmed: 29771869
Bull World Health Organ. 1995;73(5):621-30
pubmed: 8846488
Sex Transm Infect. 2017 Feb;93(1):4-5
pubmed: 27084840
Sex Transm Dis. 2017 Apr;44(4):211-218
pubmed: 28282646
Sex Transm Infect. 2001 Apr;77(2):125-9
pubmed: 11287692
Ann Emerg Med. 2019 Jul;74(1):36-44
pubmed: 30392736
PLoS One. 2015 Jul 13;10(7):e0132776
pubmed: 26168051
BMC Infect Dis. 2015 Aug 19;15:343
pubmed: 26286546
Sex Health. 2018 Feb;15(1):1-12
pubmed: 28838352
Sex Reprod Healthc. 2011 Jan;2(1):13-20
pubmed: 21147454
BMC Infect Dis. 2018 Oct 3;18(1):499
pubmed: 30285705
PLoS One. 2010 Nov 30;5(11):e14144
pubmed: 21152386
BMJ Open. 2018 Sep 10;8(9):e020394
pubmed: 30201794
Clin Infect Dis. 2005 Nov 1;41(9):1304-12
pubmed: 16206106
Clin Vaccine Immunol. 2017 Oct 5;24(10):
pubmed: 28835360
Sex Transm Dis. 2018 Jan;45(1):56-60
pubmed: 29240635
N Engl J Med. 2017 Feb 23;376(8):765-773
pubmed: 28225683
Sex Transm Dis. 2010 Mar;37(3):159-64
pubmed: 19901864
Lancet. 2009 Aug 1;374(9687):416-22
pubmed: 19616840
Sex Transm Dis. 2010 Dec;37(12):756-63
pubmed: 20644498
Sex Transm Infect. 2017 Dec;93(S4):S3-S15
pubmed: 28747410
Bull World Health Organ. 2009 Nov;87(11):858-65
pubmed: 20072772
Lancet Infect Dis. 2019 Jun;19(6):570-571
pubmed: 31036512
Sex Transm Dis. 2018 Jan;45(1):61-68
pubmed: 29240636
Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
pubmed: 1595015
J Infect Dis. 2017 Jul 15;216(suppl_2):S389-S395
pubmed: 28838078
Sex Transm Infect. 2008 Oct;84(5):364-70
pubmed: 18375645